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Abstract
Introduction: Lactococcus garvieae is a well-recognized fish pathogen, and it is considered a rare pathogen with
low virulence in human infection. We describe the 11th case of L. garvieae infective endocarditis reported in the
literature, and the first reported case in Japan.
Case presentation: We report a case of a 55-year-old Japanese woman who had native valve endocarditis with L.
garvieae. The case was complicated by renal infarction, cerebral infarction, and mycotic aneurysms. After anti-
microbial treatment, she was discharged from the hospital and is now well while being monitored in the out-
patient clinic.
Conclusion: We encountered a case of L. garvieae endocarditis that occurred in a native valve of a healthy
woman. The 16S ribosomal RNA gene sequencing was useful for the identification of this pathogen. Although
infective endocarditis with L. garvieae is uncommon, it is possible to treat high virulence clinically.
Introduction
Lactococcus garvieae was first isolated from cases of
bovine mastitis [1], and it is rarely reported in human
infection. The first human infection was documented as
infective endocarditis (IE) in 1991 [2]. Since then, it has
been identified as a pathogen in IE [3-9], liver abscess
[10], and osteomyelitis [4]. We describe the 11th case of
L. garvieae IE reported in the literature, and the first
reported case in Japan.
Case presentation
A 55-year-old healthy Japanese woman presented to our
hospital with a two-month history of malaise and myal-
gia, and she had had a fever for one month. The patient
had no significant medical history and no relevant his-
tory regarding pets, travel, dental treatment, or drug
abuse. Her occupational history was that she worked at
an import grocery store. During her physical examina-
tion, we noted her body temperature of 37.6°C, a grade
2 systolic murmur at the apex, and a painful 1 mm
black induration on her right forefinger. Trans-thoracic
echocardiography showed a 1 cm mobile mass on the
mitral valve with moderate mitral regurgitation. Her
laboratory tests showed a white blood cell count of
8200/μL, a C-reactive protein level of 6.6 mg/dL, and a
hemoglobin level of 9.9 g/dL. Gram-positive cocci form-
ing pairs or short chains were shown by Gram staining
of three sets of blood cultures drawn at the time of
admission.
IE was diagnosed on the basis of the Duke criteria for
the diagnosis of infective endocarditis [11] (two major
and two minor criteria) and antibiotic treatment with
benzylpenicillin 3 million units every four hours and
gentamicin 60 mg every eight hours was started, as
Streptococcus sp. was suspected as the causative patho-
gen. Subsequently, the rapid ID32 Strep (bioMérieux,
Marcy-l’Etoile, France) profile (code 34323501010)
revealed L. garvieae. We also performed molecular spe-
cies identification by 16S ribosomal RNA gene (16S
rRNA) sequencing, and the almost full-length 16S
rDNA matched L. garvieae (99.9%). The results of an
anti-microbial susceptibility test using Etest strips (AB
Biodisk, Dalvagen, Solna, Sweden) showed the following
values: erythromycin 0.25 mg/L, clindamycin ≥ 256 mg/
L, vancomycin 0.38 mg/L, linezolid 2.0 mg/L, penicillin
0.5 mg/L, ceftriaxone 0.38 mg/L, gentamicin 1.5 mg/L,
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we changed the anti-microbial treatment to intravenous
ceftriaxone 2 g every 12 hours and gentamicin 80 mg
every eight hours intraveneously.
Meanwhile, her body temperature rose to 39°C with
left lower back pain on her sixth day in the hospital.
Left-sided renal infarction was diagnosed on the basis of
contrast-enhanced computed tomography (CT) (Figure
1). On the 12th hospital day, cerebral infarction
occurred, followed by a sudden onset of right-sided
hemiparesis and slurred speech (National Institutes of
Health Stroke Scale (NIHSS) score 12). Diffusion-
weighted MRI showed a cerebral infarction of the mid-
dle cerebral artery area (Figure 2). Furthermore, cerebral
mycotic aneurysms were detected by three-dimensional
CT angiography on the 24th hospital day (Figure 3).
The patient also developed aspiration pneumonia after
the cerebral infarction complication.
Anti-microbial treatment was completed in nine
weeks, including the treatment for pneumonia. Several
repeat blood cultures thereafter were all negative. The
vegetation on the mitral valve was no longer detected by
trans-esophageal echocardiography performed just
before she was discharged from the hospital. We found
by CT that her left-sided renal infarction had improved,
and the consequences of her cerebral infarction had also
improved with only right-sided muscular weakness
(NIHSS score 2). She was discharged from the hospital,
and she is now well while being monitored in the out-
patient clinic.
Discussion
Genus Lactococcus was separated from genus Streptococ-
cus in 1985 based on DNA-DNA relatedness and 16S
rRNA sequencing data published by Ludwig et al. [12].
The genus Lactococcus was classified into eight species
and sub-species by Facklam and Elliott in 1995 [13] and
Pu et al. in 2002 [14]: L. lactis ssp. l a c t i s ,L .l a c t i sssp.
c r e m o r i s ,L .l a c t i sssp. hordniae, L. garvieae, L. piscium,
L. plantarum, L. raffinolactis,a n dL. xyloses.C a s e s
involving the L. garvieae pathogen in human infection
are rarely reported [2-10]. The major clinical presenta-
tion is IE, which has been reported in 10 cases in the
Figure 1 Contrast-enhanced abdominal computed tomography.
Yellow arrow indicates left renal infarction.
Figure 2 Diffusion-weighted MRI scan. Yellow arrow indicates the
middle cerebral artery areas of high signal intensity.
Figure 3 Three-dimensional computed tomography
angiography. The two yellow circles indicate cerebral mycotic
aneurysms.
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[3,6-9], and four cases required surgery for valve repla-
cement [3,6,8,9]. In addition, two cases were compli-
cated by cerebral infarction or hemorrhage [3,9]. L.
garvieae IE is uncommon; however, the virulence of L.
garvieae might be underestimated. The treatment for L.
garvieae IE is not standardized, because the exact criter-
ion of the susceptibility test has not been established. In
the published cases, penicillin combined with gentami-
cin, amoxicillin combined with netilmicin, ampicillin,
ceftriaxone, and vancomycin were used as anti-microbial
treatment. In our case, the results of the anti-microbial
susceptibility test of the isolate using the Etest method
was susceptibility to ceftriaxone (0.38 mg/L), erythromy-
cin (0.25 mg/L), vancomycin (0.38 mg/L), and linezolid
(2 mg/L), less susceptibility to penicillin (0.5 mg/L), and
resistance to clindamycin (> 256 mg/L).
Elliott and Facklam [15] reported that clindamycin
resistance is a feature of L. garvieae, and this feature can
be used to distinguish it from other lactococci. To con-
firm the precise identification, various molecular techni-
ques are available: whole-cell protein analysis, 16S rRNA
gene sequencing, and sodAint (an internal fragment of
the sodA gene encoding the manganese-dependent
superoxide dismutase) gene sequencing.
L. garvieae has pathogenicity for several fish species,
ruminants, and humans. Therefore, it could be a poten-
tially zoonotic infection. Investigators in one recent
report hypothesized that eating infected raw fish carrying
L. garvieae caused its infection [7]. To investigate the
relationship between our isolate and fish isolates, the
immunological property was examined by using several
anti-sera against L. garvieae that have previously been
produced by fish in Japan. The results showed that our
isolate did not have a capsule detected by any anti-cap-
sule antibody for fish isolates. Pulsed-field gel electro-
phoresis also showed that the pattern of our isolate was
quite different from that of fish-derived strains (data not
shown). Vela et al. [16] found great phenotypic heteroge-
neity and genetic diversity among the L. garvieae isolates
from fish, cows, water buffalo, and humans, with a gener-
ally good correlation between the phenotypic and genetic
properties of L. garvieae. As the origin of the L. garvieae
strain in our patient could not be clarified by the investi-
gations used to detect Japanese fish pathogens, other
causes of her infection, such as cow’s milk or cheeses, are
possible. To confirm the etiology of the transmission of
L. garvieae, larger molecular epidemiological studies
including investigating causes from the environment, ani-
mals, and humans must be carried out.
Conclusion
Herein we report the first case of L. garvieae IE in
Japan. Molecular biological investigation techniques
such as 16S ribosomal RNA gene sequencing are useful
for the identification of L. garvieae. Although L. gar-
vieae is considered a rare pathogen with low virulence
in human infection, it could cause native valve endo-
carditis in healthy people. It might be necessary
to review the precise estimation of the pathogenicity of
L. garvieae.
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